RO-7300490

N/A

Report date: 2025/01/13 17:01:51

Base Information

Drug NameRO-7300490
Drug Alias NameRO-7300490RG-6189FAP-CD40FAP-huCD40
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionFibroblast activation protein alpha antagonistsTumor necrosis factor receptor superfamily member 5 agonists
TargetsProlyl endopeptidase FAPTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited KingdomFrance +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank